Global Cytotoxic Drugs Market Growth, Size, Share, Industry Report and Forecast 2020-2026
The global cytotoxic drugs market is estimated to grow at a CAGR of nearly 1.3% during the forecast period. Significant rise in cancer incidences has led the demand for chemotherapy which utilizes specialized medications to reach and kill cancer cells in a part of the body, rather than surgery and radiation, which target particular areas. As per the World Health Organization (WHO), in 2018, the cancer burden across the globe is anticipated to have increased to 18.1 million new incidences and 9.6 million mortalities. Globally, one in 5 men and one in 6 women develop cancer in their lifetime. Globally, 43.8 million patients were suffering from cancer in 2018.
To Request a Free Sample of our Global Cytotoxic Drugs Market: https://www.omrglobal.com/request-sample/cytotoxic-drugs-market
Chemo is regarded as a systemic treatment as the drugs travel
in all over the body and kill cancerous cells that have spread to body parts
far away from the primary tumor, which makes it different from other cancer
treatments such as radiation and surgery. Surgery is used for tumor removal
from a body part where cancer has been detected. Radiation therapy is intended at
a certain area of the body to damage or kill cancerous cells. These are known
as local treatments as they affect one part of the body. Chemotherapy involves
the use of cytotoxic drugs to kill cancer cells. These drugs restrict the
division of cells and thereby kills cancerous cells. The therapy can be
potential outside the primary tumor as well as destroy small tumors that have
not been identified in tests.
In addition, it aims to improve immune cell recognition of cancer, while offered in combination with Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) immune checkpoint inhibitor Yervoy (ipilimumab) of Bristol Myers Squibb. This combination will be assessed among patients suffering from advanced sarcoma, liver cancer, and breast cancer, in a range of new cohorts under IT-01, current Phase 1/2 clinical trial of Intensity. Bristol Myers Squibb will supply Yervoy for the study and Intensity will sponsor and conduct the clinical trial. Such kinds of clinical studies will offer an opportunity for the introduction of combined therapies for the treatment of cancer, which in turn, will likely drive the global cytotoxic drugs market.
A full Report of Global Cytotoxic
Drugs Market is Available at: https://www.omrglobal.com/industry-reports/cytotoxic-drugs-market
Global Cytotoxic
Drugs Market- Segmentation
·
Alkylating
·
Antimetabolites
·
Antitumor Antibiotics
·
Plant Alkaloids
· Others
By Application
·
Lung Cancer
·
Breast Cancer
·
Prostate Cancer
·
Pancreatic Cancer
·
Others
North
America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of The
World
Company Profiles
·
AbbVie Inc.
·
Amgen Inc.
·
Bayer AG
·
Bristol Myers Squibb Co.
·
Cipla Ltd.
·
Daiichi Sankyo Company, Ltd.
·
Eli Lilly and Co.
·
F. Hoffman La-Roche AG
·
Fresenius SE & Co. KGaA
·
GlaxoSmithKline plc
·
Johnson & Johnson Services, Inc.
·
Lonza Group Ltd.
·
Lupin Ltd.
·
Merck & Co., Inc.
·
Mylan N.V.
·
Novartis International AG
·
Pfizer Inc.
·
Sanofi S.A.
·
Sun Pharmaceutical Industries Ltd.
·
Teva Pharmaceutical Industries Ltd.
Orion
Market Research (OMR) is a market research and consulting company known for its
crisp and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services.
For More Information, Visit Orion
Market Research
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment